157 related articles for article (PubMed ID: 21146154)
1. Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts.
Ravosa MJ; Ning J; Liu Y; Stack MS
Arch Oral Biol; 2011 May; 56(5):491-8. PubMed ID: 21146154
[TBL] [Abstract][Full Text] [Related]
2. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
Scheper MA; Badros A; Chaisuparat R; Cullen KJ; Meiller TF
Br J Haematol; 2009 Mar; 144(5):667-76. PubMed ID: 19036117
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates inhibit expression of p63 by oral keratinocytes.
Scheller EL; Baldwin CM; Kuo S; D'Silva NJ; Feinberg SE; Krebsbach PH; Edwards PC
J Dent Res; 2011 Jul; 90(7):894-9. PubMed ID: 21551338
[TBL] [Abstract][Full Text] [Related]
5. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
6. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.
Anitua E; Zalduendo M; Troya M; Orive G
Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of zoledronic acid on oral mucosal epithelial cells.
Allam E; Allen M; Chu TM; Ghoneima A; Jack Windsor L
Oral Dis; 2011 Apr; 17(3):291-7. PubMed ID: 20860766
[TBL] [Abstract][Full Text] [Related]
8. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
Cozin M; Pinker BM; Solemani K; Zuniga JM; Dadaian SC; Cremers S; Landesberg R; Raghavan S
J Oral Maxillofac Surg; 2011 Oct; 69(10):2564-78. PubMed ID: 21807448
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of bisphosphonates on oral keratinocytes and fibroblasts.
McLeod NM; Moutasim KA; Brennan PA; Thomas G; Jenei V
J Oral Maxillofac Surg; 2014 Mar; 72(3):503-9. PubMed ID: 24342576
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of oral mucosal cell wound healing by bisphosphonates.
Landesberg R; Cozin M; Cremers S; Woo V; Kousteni S; Sinha S; Garrett-Sinha L; Raghavan S
J Oral Maxillofac Surg; 2008 May; 66(5):839-47. PubMed ID: 18423269
[TBL] [Abstract][Full Text] [Related]
12. A novel bioassay model to determine clinically significant bisphosphonate levels.
Scheper MA; Badros A; Salama AR; Warburton G; Cullen KJ; Weikel DS; Meiller TF
Support Care Cancer; 2009 Dec; 17(12):1553-7. PubMed ID: 19653010
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice.
Akita Y; Kuroshima S; Nakajima K; Hayano H; Kanai R; Sasaki M; Sawase T
J Bone Miner Metab; 2018 Sep; 36(5):547-559. PubMed ID: 29043461
[TBL] [Abstract][Full Text] [Related]
14. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates induce senescence in normal human oral keratinocytes.
Kim RH; Lee RS; Williams D; Bae S; Woo J; Lieberman M; Oh JE; Dong Q; Shin KH; Kang MK; Park NH
J Dent Res; 2011 Jun; 90(6):810-6. PubMed ID: 21427353
[TBL] [Abstract][Full Text] [Related]
16. Increased risk for bisphosphonate-related osteonecrosis of the jaws in patients wearing dentures could be attributable to impaired mucosal cell wound healing.
Kyrgidis A; Vahtsevanos K
J Oral Maxillofac Surg; 2009 Jun; 67(6):1355-6. PubMed ID: 19446234
[No Abstract] [Full Text] [Related]
17. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid impairs re-epithelialization through down-regulation of integrin αvβ6 and transforming growth factor beta signalling in a three-dimensional in vitro wound healing model.
Saito T; Izumi K; Shiomi A; Uenoyama A; Ohnuki H; Kato H; Terada M; Nozawa-Inoue K; Kawano Y; Takagi R; Maeda T
Int J Oral Maxillofac Surg; 2014 Mar; 43(3):373-80. PubMed ID: 24021731
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
20. Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction.
Migliorati CA; Saunders D; Conlon MS; Ingstad HK; Vaagen P; Palazzolo MJ; Herlofson BB
J Am Dent Assoc; 2013 Apr; 144(4):406-14. PubMed ID: 23543695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
